Issue 2/2013
Content (22 Articles)
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Zsuzsanna Mihály, Máté Kormos, András Lánczky, Magdolna Dank, Jan Budczies, Marcell A Szász, Balázs Győrffy
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials
Fausto Petrelli, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Veronica Lonati, Sandro Barni
Systematic review of radioguided versus wire-guided localization in the treatment of non-palpable breast cancers
Muneer Ahmed, Mieke van Hemelrijck, Michael Douek
Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study
Maria Afentakis, Mitch Dowsett, Ivana Sestak, Janine Salter, Tony Howell, Aman Buzdar, John Forbes, Jack Cuzick
Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast
Aram S. A. van Brussel, Arthur Adams, Jeroen F. Vermeulen, Sabrina Oliveira, Elsken van der Wall, Willem P. Th. M. Mali, Paul. J. van Diest, Paul M. P. van Bergen en Henegouwen
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice
Lu Wang, Yufeng Xie, Khawaja Ashfaque Ahmed, Shahid Ahmed, Amer Sami, Rajni Chibbar, Qingyong Xu, Susan E. Kane, Siguo Hao, Sean J. Mulligan, Jim Xiang
Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time
G. L. Chew, D. Huang, C. W. Huo, T. Blick, P. Hill, J. Cawson, H. Frazer, M. D. Southey, J. L. Hopper, M. A. Henderson, I. Haviv, E. W. Thompson
Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
Yasuto Naoi, Kazuki Kishi, Ryo Tsunashima, Kenzo Shimazu, Atsushi Shimomura, Naomi Maruyama, Masafumi Shimoda, Naofumi Kagara, Yosuke Baba, Seung Jin Kim, Shinzaburo Noguchi
The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer
Hany Onsy Habashy, Emad A. Rakha, Ian O. Ellis, Desmond G. Powe
Lack of circadian variation and reduction of heart rate variability in women with breast cancer undergoing lumpectomy: a descriptive study
Melissa V. Hansen, Jacob Rosenberg, Ismail Gögenur
Increased expression of Mitotic Arrest Deficient-Like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer
Qian Sun, Xianyu Zhang, Tong Liu, Xiaolong Liu, Jingshu Geng, Xiaohui He, Yang Liu, Da Pang
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
Erica L. Mayer, M. E. Scheulen, J. Beckman, H. Richly, A. Duarte, M. M. Cotreau, A. L. Strahs, S. Agarwal, L. Steelman, E. P. Winer, M. N. Dickler
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy
Linda T. Vahdat, Agustin A. Garcia, Charles Vogel, Christine Pellegrino, Deborah L. Lindquist, Nicholas Iannotti, Prashanth Gopalakrishna, Joseph A. Sparano
Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy
Andrea L. Russo, Nils D. Arvold, Andrzej Niemierko, Nathan Wong, Julia S. Wong, Jennifer R. Bellon, Rinaa S. Punglia, Mehra Golshan, Susan L. Troyan, Jane E. Brock, Jay R. Harris
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial
V. O. Dezentjé, R. H. N. van Schaik, J. M. Vletter-Bogaartz, T. van der Straaten, J. A. M. Wessels, E. M.-K. Kranenbarg, E. M. Berns, C. Seynaeve, H. Putter, C. J. H. van de Velde, J. W. R. Nortier, H. Gelderblom, H.-J. Guchelaar
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations
Laufey Tryggvadottir, Elinborg J. Olafsdottir, Gudridur H. Olafsdottir, Helgi Sigurdsson, Oskar T. Johannsson, Einar Bjorgvinsson, Kristin Alexiusdottir, Olafur A. Stefansson, Bjarni A. Agnarsson, Steven A. Narod, Jorunn E. Eyfjord, Jon G. Jonasson
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
Natalia Garcia-Giralt, María Rodríguez-Sanz, Daniel Prieto-Alhambra, Sonia Servitja, Elisa Torres-del Pliego, Susana Balcells, Joan Albanell, Daniel Grinberg, Adolfo Diez-Perez, Ignasi Tusquets, Xavier Nogués
Rates and predictors of consideration for adjuvant radiotherapy among high-risk breast cancer patients: a cohort study
Stanimira Krotneva, Kristen Reidel, Mohammed Nassif, Nora Trabulsi, Nancy Mayo, Robyn Tamblyn, Ari N. Meguerditchian
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
Victoria Blinder, Sujata Patil, Carolyn Eberle, Jennifer Griggs, Rose C. Maly
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care
Sarah L. Elson, Robert A. Hiatt, Hoda Anton-Culver, Lydia P. Howell, Arash Naeim, Barbara A. Parker, Laura J. van’t Veer, Michael Hogarth, John P. Pierce, Robert J. DuWors, Kathy Hajopoulos, Laura J. Esserman
The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk
Shaneda Warren Andersen, Amy Trentham-Dietz, Ronald E. Gangnon, John M. Hampton, Jonine D. Figueroa, Halcyon G. Skinner, Corinne D. Engelman, Barbara E. Klein, Linda J. Titus, Polly A. Newcomb